Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities
Authors:
- A. DienelADA. Dienel
- M. KieserMKM. Kieser
- 1 December 1998
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 5 (6) , 435-442
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hyperforin, Possibly the Major Non-Nitrogenous Secondary Metabolite of Hypericum perforatum L.Pharmacopsychiatry, 1998
- LI 160, an Extract of St. John's Wort, Versus Amitriptyline in Mildly to Moderately Depressed Outpatients - A Controlled 6-Week Clinical TrialPharmacopsychiatry, 1997
- EditorialPharmacopsychiatry, 1997
- Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in HumansPharmacopsychiatry, 1997
- Biologically Active and Other Chemical Constituents of the Herb ofHypericum perforatumL.Pharmacopsychiatry, 1997
- Mood disorders in the general population represent an important and worldwide public health problemInternational Clinical Psychopharmacology, 1995
- Pharmaceutical Quality of Hypericum ExtractsJournal of Geriatric Psychiatry and Neurology, 1994
- Adhyperforin: A Homologue of Hyperforin fromHypericum perforatumPlanta Medica, 1992
- Inhibition of Monoamine Oxidase by HypercinPlanta Medica, 1984
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960